| Induction of ovarian cancer by defined multiple genetic changes in a mouse model system S Orsulic, Y Li, RA Soslow, LA Vitale-Cross, JS Gutkind, HE Varmus Cancer cell 1 (1), 53-62, 2002 | 415 | 2002 |
| Parasympathetic innervation maintains epithelial progenitor cells during salivary organogenesis SM Knox, IMA Lombaert, X Reed, L Vitale-Cross, JS Gutkind, MP Hoffman Science 329 (5999), 1645-1647, 2010 | 394 | 2010 |
| The head and neck cancer cell oncogenome: a platform for the development of precision molecular therapies D Martin, MC Abba, AA Molinolo, L Vitale-Cross, Z Wang, M Zaida, ... Oncotarget 5 (19), 8906, 2014 | 214 | 2014 |
| Assembly and activation of the Hippo signalome by FAT1 tumor suppressor D Martin, MS Degese, L Vitale-Cross, R Iglesias-Bartolome, JLC Valera, ... Nature communications 9 (1), 2372, 2018 | 168 | 2018 |
| Conditional expression of K-ras in an epithelial compartment that includes the stem cells is sufficient to promote squamous cell carcinogenesis L Vitale-Cross, P Amornphimoltham, G Fisher, AA Molinolo, JS Gutkind Cancer research 64 (24), 8804-8807, 2004 | 166 | 2004 |
| Metformin prevents the development of oral squamous cell carcinomas from carcinogen-induced premalignant lesions L Vitale-Cross, AA Molinolo, D Martin, RH Younis, T Maruyama, V Patel, ... Cancer prevention research 5 (4), 562-573, 2012 | 164 | 2012 |
| Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4 Z Wang, VH Wu, MM Allevato, M Gilardi, Y He, J Luis Callejas-Valera, ... Nature communications 10 (1), 5546, 2019 | 145 | 2019 |
| mTOR Co-Targeting in Cetuximab Resistance in Head and Neck Cancers Harboring PIK3CA and RAS Mutations Z Wang, D Martin, AA Molinolo, V Patel, R Iglesias-Bartolome, ... Journal of the National Cancer Institute 106 (9), dju215, 2014 | 116 | 2014 |
| Chemical carcinogenesis models for evaluating molecular-targeted prevention and treatment of oral cancer L Vitale-Cross, R Czerninski, P Amornphimoltham, V Patel, AA Molinolo, ... Cancer prevention research 2 (5), 419-422, 2009 | 109 | 2009 |
| Inhibition of mTOR signaling and clinical activity of rapamycin in head and neck cancer in a window of opportunity trial TA Day, K Shirai, PE O'Brien, MG Matheus, K Godwin, AJ Sood, ... Clinical Cancer Research 25 (4), 1156-1164, 2019 | 93 | 2019 |
| 4E-BP1 is a tumor suppressor protein reactivated by mTOR inhibition in head and neck cancer Z Wang, X Feng, AA Molinolo, D Martin, L Vitale-Cross, N Nohata, M Ando, ... Cancer research 79 (7), 1438-1450, 2019 | 73 | 2019 |
| Prevention of Tumor Growth Driven by PIK3CA and HPV Oncogenes by Targeting mTOR Signaling with Metformin in Oral Squamous Carcinomas Expressing OCT3 D Madera, L Vitale-Cross, D Martin, A Schneider, AA Molinolo, ... Cancer prevention research 8 (3), 197-207, 2015 | 66 | 2015 |
| LKB1/AMPK and PKA control ABCB11 trafficking and polarization in hepatocytes L Homolya, D Fu, P Sengupta, M Jarnik, JP Gillet, L Vitale-Cross, ... PloS one 9 (3), e91921, 2014 | 63 | 2014 |
| Liver kinase B1 regulates hepatocellular tight junction distribution and function in vivo N Porat‐Shliom, AJ Tietgens, CM Van Itallie, L Vitale‐Cross, M Jarnik, ... Hepatology 64 (4), 1317-1329, 2016 | 50 | 2016 |
| Rapid development of salivary gland carcinomas upon conditional expression of K-ras driven by the cytokeratin 5 promoter AR Raimondi, L Vitale-Cross, P Amornphimoltham, JS Gutkind, ... The American journal of pathology 168 (5), 1654-1665, 2006 | 45 | 2006 |
| Vasopressin stimulates the proliferation and differentiation of red blood cell precursors and improves recovery from anemia B Mayer, K Németh, M Krepuska, VD Myneni, D Maric, JF Tisdale, ... Science translational medicine 9 (418), eaao1632, 2017 | 40 | 2017 |
| SARS-CoV-2 entry sites are present in all structural elements of the human glossopharyngeal and vagal nerves: clinical implications L Vitale-Cross, I Szalayova, A Scoggins, M Palkovits, E Mezey EBioMedicine 78, 2022 | 33 | 2022 |
| The pathway linking small GTP-binding proteins of the Rho family to cytoskeletal components and novel signaling kinase cascades JS Gutkind, L Vitale-Cross Seminars in Cell & Developmental Biology 7 (5), 683-690, 1996 | 18 | 1996 |
| Bone marrow-derived mesenchymal stromal cells (MSCs) modulate the inflammatory character of alveolar macrophages from sarcoidosis patients I McClain Caldwell, C Hogden, K Nemeth, M Boyajian, M Krepuska, ... Journal of clinical medicine 9 (1), 278, 2020 | 16 | 2020 |
| Immunogenic potential of human bone marrow mesenchymal stromal cells is enhanced by hyperthermia IAN McClain-Caldwell, L Vitale-Cross, B Mayer, M Krepuska, M Boyajian, ... Cytotherapy 20 (12), 1437-1444, 2018 | 16 | 2018 |
